收盘价:Jul 24, 16:00:00 GMT-4
盘后:Jul 24, 20:00:00 GMT-4
No Data Yet
Johnson & Johnson received FDA marketing authorization for its OTTAVA robotic surgical system, clearing the company to compete with Intuitive Surgical in the soft-tissue robotics market.
Intuitive Surgical shares dropped more than 12% in pre-market trading after the company maintained its 2026 da Vinci procedure growth forecast of 13.5% to 15.5%, overshadowing a second-quarter earnings beat.
Intuitive Surgical shares fell 12% after the company reported Q2 2026 earnings with moderated US procedure growth and guided to its slowest expansion in years.
Intuitive Surgical reported Q2 2026 revenue of $2.89 billion, up 19% year-over-year, and adjusted EPS of $2.80, beating Wall Street consensus estimates.
Intuitive Surgical Inc 的市盈率是 52.8281
Mr. David Rosa 是 Intuitive Surgical Inc 的 Chief Executive Officer,自 2011 加入公司。
ISRG 的当前价格为 $336.05,在上个交易日 下降 了 0.42%。
Intuitive Surgical Inc 属于 Health Care 行业,该板块是 Health Care
Intuitive Surgical Inc 的当前市值是 $119.0B
据华尔街分析师称,共有 32 位分析师对 Intuitive Surgical Inc 进行了分析师评级,包括 12 位强烈买入,15 位买入,12 位持有,1 位卖出,以及 12 位强烈卖出